Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited (Teva) is a pharmaceutical company engaged in the development, production, and marketing of a range of generic and branded pharmaceuticals, biogenerics and active pharmaceutical ingredients (APIs). The company's products focus on various therapeutic areas including multiple sclerosis, Parkinson's disease, autoimmune diseases, oncology, women's health and respiratory products. Its principal pipeline products include Copaxone for Multiple Sclerosis and Azilect for Parkinson's disease. Teva operates in 60 countries across the world including Israel, Europe, Asia, North America and Latin America. The company has 38 finished dosage pharmaceutical manufacturing sites, 21 API manufacturing sites and 15 generic research and development centers. The company is headquartered in Tikva, Israel.The company reported revenues of (U.S. Dollars) USD 13,899.00 million during the fiscal year ended December 2009, an increase of 25.39% over 2008. The operating profit of the company was USD 2,405.00 million during the fiscal year 2009, an increase of 110.04% over 2008. The net profit of the company was USD 2,000.00 million during the fiscal year 2009, an increase of 228.41% over 2008.